Michael E. Driscoll

Michael E. Driscoll

Founder at Metamarkets Group, Inc.

Technology Services
Consumer Services
Government

Profile

Michael E.
Driscoll
was the founder of Rill Data, Inc. (2020), CustomInk LLC (1999), and Metamarkets Group, Inc. (2010), where he holds the titles of Director, Chief Executive Officer & Director, respectively.
Dr. Driscoll is also the founder of Dataspora LLC.
He is currently a Director at Imperium3 New York, Inc. Dr. Driscoll's former positions include Software Engineer at Human Genome Sciences, Inc. and Genset Corp., Principal at National Heart, Lung & Blood Institute and National Center for Biotechnology Information, and Founding Partner at DCVC Management Co. LLC.
Dr. Driscoll's education includes an undergraduate degree from Harvard University and a doctorate from Boston University.

Michael E. Driscoll active positions

CompaniesPositionStart
Founder 01/06/2010
Director/Board Member -
All active positions of Michael E. Driscoll

Former positions of Michael E. Driscoll

CompaniesPositionEnd
Founder -
Corporate Officer/Principal -
Corporate Officer/Principal -
Private Equity Investor -
National Heart, Lung & Blood Institute Corporate Officer/Principal -
See the detail of Michael E. Driscoll's experience

Training of Michael E. Driscoll

Boston University Doctorate Degree
Harvard University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael E. Driscoll's experience

Connections

17

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Retail Trade

Commercial Services

Technology Services

National Center for Biotechnology Information

Government

National Heart, Lung & Blood Institute

Government

Finance

Health Technology

Health Technology

Technology Services

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Michael E. Driscoll
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW